Table 3.
Substrate | Biorecognition Element |
Biomarker | Technique | LOD | Working Range |
Sample | Response Time |
Year | Ref. |
---|---|---|---|---|---|---|---|---|---|
Optic fiber | Antibody | CRP | SPR | 1.17 μg/mL | 0.01–20 ug/mL | PBS buffer | / | 2017 | [89] |
Optic fiber | Antibody | PCT | LSPR | 95 fg/mL | 1–100 ng/mL | Human serum | <15 min | 2019 | [90] |
AuNPs | Aptamers | IL-6 | LSPR | 1.95 μg/mL | 3.3–125 μg/mL | mixed protein solution | 5 min | 2020 | [91] |
gold nanohole array (Au-NHA) |
Antibody | CRP | Interferometry | 18 mg/mL | 0–250 μg/mL | spiked PBS sample | 1 min after sample incubation |
2019 | [92] |
Antibody | IL-6 | 88 mg/mL | 0–400 μg/mL | ||||||
DNA capture probe | miRNA-16 | 6 mg/mL | 0.8–12.5 μg/mL | ||||||
AuNPs | electrostatic | urease | LSPR | 0.8 μg/mL | 0.8–12.5 μg/mL | broth culture | 40 min | 2019 | [93] |
AgNPs@BP | Aptamers | CRP | SERS | 100 fg/mL | 10−4–10 ng/mL | Human serum | / | 2022 | [94] |
IL-6 | 0.1 fg/mL | 10−7–10−2 ng/mL | |||||||
PCT | 1.0 fg/mL | 10−6–10−1 ng/mL | |||||||
/ | Photocatalysis | S. capitis | Colorimetry | 103 CFU/mL | 102–108 CFU/mL | Whole blood | <5 h | 2021 | [95] |
E. coli | |||||||||
AgMNPs/CPs | Label-free | IL-3 | SERS | 1000 fM | 1 pM–100 nM | Sterile human serum | Real time | 2022 | [96] |
PCT | 100 fM | 100 fM–100 nM | |||||||
Silicon chip | Antibody | CRP | WLRS | 1 ng/mL | 0.05–200 μg/mL | Human plasma | 12 min | 2021 | [97] |
Abbreviations: SPR surface plasmon resonance, LSPR localized surface plasmon resonance, AuNPs gold nanoparticles, BP black phosphorous, SERS surface enhanced Raman scattering, AgMNPs silver magnetic nanoparticles, WLRS white light reflectance spectroscopy.